Last updated: 2026-09-08 10:19:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Aclarion, Inc. (ACON) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $2.36, with a market capitalisation of $6.77M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.95 to $12.03. This page covers its latest market performance, valuation, price trends and company information.
$6.77M | |
$2.36 | |
$586,116.00 | |
$1.95 | |
-- | |
1.00 | |
61.47K | |
-- | |
$12.03 | |
$1.95 | |
-- | |
-- |
Aclarion, Inc. (ACON) is trading at $2.31 in pre-market trading as of 2026-09-08 08:23:00, -- from the previous close of $0.00
Pre-market trading shows how investors are pricing ACON before the regular session opens. The current pre-market price is -- the previous close, indicating positive early trading sentiment.
Over the past seven days, Aclarion, Inc. (ACON) moved from $2.52 to $2.36, representing a decline of 6.35% ($0.16).
The stock traded between $2.25 and $2.52 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 45.89 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 4.1%
ACON is currently trading at $2.36, placing it 4.1% of the way from its 52-week low of $1.95 to its 52-week high of $12.03. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 11 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Aclarion, Inc. (ACON) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.